Symposium

Seeing the Unseen: Early Recognition and Individualized Management of Acromegaly

Launch Date
05/14/2025 at 07:30 pm EST
Credit Amount
Credit Expires
05/14/2025

Faculty

Julie M. Silverstein, MD
Medical Director, Pituitary Center
Director, Clinical Trials Unit
Professor of Medicine and Neurological Surgery
Division of Endocrinology, Metabolism and Lipid Research
Washington University School of Medicine
St. Louis, MO
Explore By Section
Statement of Need Learning Objectives Financial Support Target Audience Credit Information Disclosure Declaration Obtaining Credit

Statement of Need

Acromegaly presents a diagnostic and management challenge due to its  gradual onset, diverse symptoms, and complex treatment landscape. Delays in diagnosis and suboptimal care lead to  prolonged morbidity and increased mortality. However,  emerging therapies, including novel oral options,  offer new opportunities for personalized treatment strategies that align with  patient preferences, adherence challenges, and comorbidities.

In this  CME Outfitters live symposium, leading experts  will explore:
✅ Early, guideline-based diagnosis  to improve patient outcomes
✅ The latest efficacy and safety data  on current and emerging therapies, including oral treatments
✅ Individualized care strategies  that consider patient needs, comorbidities, and barriers to adherence

Stay ahead of the curve with cutting-edge insights  to enhance patient care and optimize long-term management of acromegaly.

Learning Objectives

At the conclusion of this activity, learners will be able to better:

  • Integrate strategies aligned with guideline recommendations to diagnose acromegaly early in the disease course
  • Assess the latest efficacy and safety data on current and emerging treatments for acromegaly, including novel oral therapies
  • Incorporate factors including patient preferences, comorbidities, and potential barriers to adherence as part of individualized care planning to optimize long-term management of acromegaly

Financial Support

This program is supported by an educational grant from Crinetics Pharmaceuticals.

Target Audience

Endocrinologists, physician associates (PAs), nurse practitioners (NPs), nurses, and other HCPs who manage patients with acromegaly

Credit Information

Jointly Accredited Provider

In support of improving patient care, CME Outfitters, LLC, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physicians (ACCME) 1.5

CME Outfitters, LLC, designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses (ANCC) 1.5

This activity is designated for 1.50 contact hours.

California Residents: Provider approved by the California Board of Registered Nursing, Provider # CEP 15510, for 1.50 Contact Hours.

Physician Assistants (AAPA): 1.5

CME Outfitters, LLC, has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.50 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

ABIM MOC 1.5

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.50 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

MIPS Improvement Activity

Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.

Royal College MOC

Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Faculty

Dr. Silverstein reports the following financial relationships:

Research Grants: AbbVie Inc.; Ascendis; Bayer; Camurus; Chiasma Pharmaceutical; Debiopharm; Fractyl Health, Inc.; Neurocrine Biosciences, Inc.; Recordati; and Sparrow Pharmaceuticals

Planner

Ms. Sisco reports the following financial relationships:
Advisory Board: Camurus; Chiesi USA, Inc.; Crinetics Pharmaceuticals, Inc.; and Pfizer Inc.
Consultant: Camurus; Chiesi USA, Inc.; and Recordati Rare Diseases Inc.

The following individuals have no financial relationships to disclose:

Thai Nguyen, MD, MHA (Peer Reviewer)
Jessica Giddens, DNP, APRN, FPMHNP-BC, RN-BC (Peer Reviewer)
Susan Perry (Planning Committee)
Felicia Oyedepo, MD (Planning Committee)
Scott J. Hershman, MD, FACEHP, CHCP (Planning Committee)
Sandra Caballero, PharmD (Planning Committee)
Sharon Tordoff (Planning Committee)

*All identified conflicts of interest have been mitigated.

Unlabeled Use Disclosure
Faculty of this CME/CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices. CME Outfitters, LLC, the faculty, planners, and reviewers do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.

Obtaining Credit

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (0% pass rate required). This website supports all browsers except Internet Explorer for Mac.

Questions about this activity?

Call us at 877.CME.PROS (877.263.7767).

MM-155-051425-89

Seeing the Unseen: Early Recognition and Individualized Management of Acromegaly
Event Date: 05/14/2025 at 07:30 pm EST
Register